Enantioselective gas chromatographic assay with electron-capture detection for dl-ritalinic acid in plasma.
Enantioselective gas chromatographic assays for the quantitation of methylphenidate and its major metabolite ritalinic acid in plasma are described. The procedures involved the extraction of methylphenidate enantiomers from alkanised plasma. The plasma was then washed to ensure complete removal of methylphenidate before saturation with sodium carbonate to promote the extraction of ritalinic acid enantiomers with ethyl acetate-isopropanol (60:40) solvent mixture. Subsequently, ritalinic acid enantiomers were converted back into methylphenidate enantiomers by Fisher-Speier esterification. N-Heptafluorobutyryl-L-prolyl chloride, a chiral acylating reagent, was used to convert the enantiomers of methylphenidate into their corresponding diastereomeric amide derivatives, which were separated cleanly on an achiral capillary column (OV-225) and quantitated with electron-capture detection. The assays were sensitive, reliable and reproducible.
Srinivas
N R
NR
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
Hubbard
J W
JW
Midha
K K
KK
D002849:Chromatography, Gas; D004563:Electrochemistry; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D011786:Quality Control; D013237:Stereoisomerism
D008774:Methylphenidate; C009189:ritalinic acid